Novo Nordisk’s Camilla Sylvest explains how the Danish pharmaceuticals company has been collaborating with cities since 2014 to combat the global rise in type 2 diabetes. The coalition of nine cities aims to prevent 100 million new cases by 2045 by working together to tackle obesity
Tags: Business Strategy, C40, China, cities, diabetes, Mexico City, obesity, Pharmaceuticals industry, SDGs
Ethical Corporation is part of FC Business Intelligence Ltd, a registered company in England and Wales - Registered number 0438897. 7-9 Fashion Street, London, E1 6PX, UK.